Skip to content

New Treatment for Hodgkin’s Lymphoma

Consecutive inhibition of telomerase followed by ALT inhibition promotes cell death in Hodgkin's Lymphoma.

Published: 17th October 2022
New Treatment for Hodgkin’s Lymphoma
Source: Design Cells, stock.adobe.com/uk/282969790, stock.adobe.com
Patents
  • US Provisional Application 63/356,576. Filed 29 June, 2022.
IP Status
  • Provisional patent
Seeking
  • Development partner
  • Commercial partner
  • Licensing
  • University spin out
  • Seeking investment